Explore

Reuters Reuters
P&G is acquiring supplements maker Thorne for $3.8 billion, CEO Jejurikar tells CNBC

P&G is acquiring supplements maker Thorne for $3.8 billion, CEO Jejurikar tells CNBC

Aug 4 (Reuters) - Procter & Gamble will acquire supplements maker Thorne for $3.8 billion, CEO Shailesh Jejurikar told CNBC on Tuesday, as consumer goods companies expand their health and wellness offerings to tap sustained demand for self-care products.
Reuters Reuters
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Aug 2 (Reuters) - UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.
Trendline Trendline
Procter Gamble to Acquire Thorne Supplements for $3.8 Billion

Procter Gamble to Acquire Thorne Supplements for $3.8 Billion

Procter Gamble to Acquire Thorne Supplements for $3.8 Billion
Reuters Reuters
AstraZeneca investors baulk at $400 billion Bristol Myers talks

AstraZeneca investors baulk at $400 billion Bristol Myers talks

By Maggie Fick LONDON, Aug 3 (Reuters) - AstraZeneca's shares fell sharply on Monday as investors baulked at reports of merger talks with Bristol Myers Squibb about forming what would become one of the world's biggest drugmakers with a combined value of nearly $400 billion.
Reuters Reuters
AstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal

AstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal

By Maggie Fick LONDON, Aug 3 (Reuters) - AstraZeneca investors punished the pharmaceutical firm on Monday over reports of merger talks with U.S. rival Bristol Myers Squibb that could make one of the world's biggest drugmakers with a combined value of nearly $400 billion.
Reuters Reuters
Kimberly-Clark cuts annual forecasts as China quality claims hurt diaper sales

Kimberly-Clark cuts annual forecasts as China quality claims hurt diaper sales

Aug 4 (Reuters) - Kimberly-Clark cut its annual sales and profit forecasts on Tuesday, citing a significant hit to second-quarter sales in China that stemmed from what it said were false viral claims about the quality of some of its diaper brands.
Reuters Reuters
Oil prices drop 5% to three-week low after Trump cancels attack on Iran

Oil prices drop 5% to three-week low after Trump cancels attack on Iran

By Scott DiSavino NEW YORK, Aug 3 (Reuters) - Oil prices fell about 5% to a three-week low on Monday after U.S. President Donald Trump held off on a fresh attack on Iran in the hope of sealing a quick deal that could boost oil supplies from the Gulf.
Reuters Reuters
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

By Sabrina Valle and Michael Erman Aug 2 (Reuters) - AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's biggest pharmaceutical companies with a combined value of nearly $400 billion, according to a person familiar
Reuters Reuters
AstraZeneca investors balk at $400 billion Bristol Myers tie-up reports

AstraZeneca investors balk at $400 billion Bristol Myers tie-up reports

By Maggie Fick LONDON, Aug 3 (Reuters) - AstraZeneca's shares fell as investors balked on Monday at reports of merger talks with Bristol Myers Squibb about forming what would become one of the world's biggest drugmakers with a combined value of nearly $400 billion.
Reuters Reuters
Palantir lifts annual revenue forecast on steady demand for AI-powered data analytics

Palantir lifts annual revenue forecast on steady demand for AI-powered data analytics

By Jaspreet Singh and Juby Babu Aug 3 (Reuters) - Palantir Technologies on Monday raised its annual revenue forecast again, signaling strong government and commercial demand for its data analytics software, sending its shares up nearly 12% in extended trading.
Reuters Reuters
McDonald's US sales growth slows as value deals fail to draw enough diners

McDonald's US sales growth slows as value deals fail to draw enough diners

By Savyata Mishra Aug 4 (Reuters) - McDonald's on Tuesday missed U.S. sales growth expectations for the second quarter as its value deals failed to sufficiently draw lower-income diners who have been cutting back restaurant spending due to growing economic worries.
Reuters Reuters
Kimberly-Clark cuts annual forecasts as China disruption weighs on diaper sales

Kimberly-Clark cuts annual forecasts as China disruption weighs on diaper sales

Aug 4 (Reuters) - Kimberly-Clark cut its annual sales and profit forecasts on Tuesday, citing a significant hit to second-quarter sales in China that stemmed from false claims about the quality of some of its diaper brands.